India · Delayed Price · Currency is INR Theseus Pharmaceuticals Statistics
Total Valuation
BOM:543238 has a market cap or net worth of INR 169.47 billion. The enterprise value is 130.04 billion.
| Market Cap | 169.47B |
| Enterprise Value | 130.04B |
Important Dates
The last earnings date was Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | Jul 24, 2025 |
Share Statistics
| Current Share Class | 128.10M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.76% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 98.81M |
Valuation Ratios
The trailing PE ratio is 23.73 and the forward PE ratio is 20.67.
| PE Ratio | 23.73 |
| Forward PE | 20.67 |
| PS Ratio | 9.07 |
| PB Ratio | 3.28 |
| P/TBV Ratio | 3.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 18.21 |
| EV / Sales | 6.96 |
| EV / EBITDA | 11.97 |
| EV / EBIT | 12.46 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | n/a |
| Interest Coverage | 80.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 12.53% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 13.42M |
| Profits Per Employee | 5.13M |
| Employee Count | 1,393 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543238 has paid 2.44 billion in taxes.
| Income Tax | 2.44B |
| Effective Tax Rate | 23.57% |
Stock Price Statistics
The stock price has increased by +34.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +34.20% |
| 50-Day Moving Average | 1,310.92 |
| 200-Day Moving Average | 1,188.06 |
| Relative Strength Index (RSI) | 46.48 |
| Average Volume (20 Days) | 10,173 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543238 had revenue of INR 18.69 billion and earned 7.14 billion in profits. Earnings per share was 55.66.
| Revenue | 18.69B |
| Gross Profit | 13.75B |
| Operating Income | 10.44B |
| Pretax Income | 10.37B |
| Net Income | 7.14B |
| EBITDA | 10.67B |
| EBIT | 10.44B |
| Earnings Per Share (EPS) | 55.66 |
Balance Sheet
The company has 46.47 billion in cash and 1.42 billion in debt, giving a net cash position of 45.05 billion.
| Cash & Cash Equivalents | 46.47B |
| Total Debt | 1.42B |
| Net Cash | 45.05B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 51.60B |
| Book Value Per Share | 359.37 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 73.55%, with operating and profit margins of 55.87% and 38.22%.
| Gross Margin | 73.55% |
| Operating Margin | 55.87% |
| Pretax Margin | 55.48% |
| Profit Margin | 38.22% |
| EBITDA Margin | 57.11% |
| EBIT Margin | 55.87% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 48.00, which amounts to a dividend yield of 3.69%.
| Dividend Per Share | 48.00 |
| Dividend Yield | 3.69% |
| Dividend Growth (YoY) | 2.13% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | -0.76% |
| Shareholder Yield | 2.94% |
| Earnings Yield | 4.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |